FindTrial
Sign In

Assessment of stigma and QoL in Cancer patients

Assessment of stigma and QoL analysis in patients with Cancers of Breast, Head and Neck, Lungs: A hospital based prospective study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060153
Enrollment
250
Registered
2023-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 3: C341- Malignant neoplasm of upper lobe,bronchus or lung

Interventions

Control Intervention1: NIL: NIL

Sponsors

S S Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Cancer of Breast, Head and Neck, Lungs Willing to participate in the study Should not have HIV/STDs, TB, several mental disorders Should not be terminally ill

Exclusion criteria

Exclusion criteria: Cancer patients with serious co-morbid conditions Unwilling to participate Patients with HIV/STDs, TB, COVID-19 infections Terminally ill patients Patients below 10 year and above 75 years age

Design outcomes

Primary

MeasureTime frame
We can find the factors associated with Cancer related stigma in selected patients and the data of QoL will show the patients response in this study.Timepoint: 2 years—

Secondary

MeasureTime frame
Essential support may be generated for palliative care of Cancer patientsTimepoint: 1 year—

Countries

India

Contacts

Public ContactMr Sachidananda Behera

S. S. Hospital and Research Institute, Patna

parool.icmr@gmail.com9431460063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026